| Authors: |
Garralda E; Vall d'Hebron University Hospital (VHIO), Barcelona, Spain. Electronic address: egarralda@vhio.net., Schöffski P; University Hospitals Leuven, Department of General Medical Oncology, Leuven Cancer Institute KU Leuven, Leuven, Belgium., Oberoi A; Vall d'Hebron University Hospital (VHIO), Barcelona, Spain., Schuler M; West German Cancer Center, University Hospital Essen, Essen, Germany., Richly H; West German Cancer Center, University Hospital Essen, Essen, Germany., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy; Università degli Studi di Napoli 'Federico II', Napoli, Italy., Lin CC; National Taiwan University Hospital, Taipei, Taiwan., Álvarez R; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Patel SP; UC San Diego Moores Cancer Center, La Jolla, CA, USA., Xing Y; City of Hope Comprehensive Center, Duarte, CA, USA., Subbiah V; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lewis N; Novartis Pharmaceuticals, USA., Patel S; Novartis Biomedical Research, USA., Wang-L-Akshman L; Novartis Biomedical Research, USA., Lee JB; Novartis Biomedical Research, USA., Hassounah NB; Novartis Biomedical Research, USA., Lee LH; Novartis Biomedical Research, USA., Roy M; Novartis Pharmaceuticals, USA., Banerjee S; Novartis Biomedical Research, USA., Reynolds A; Novartis Biomedical Research, USA., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. |
